CClinicalTrials.gg
Status unknownNCT04345822Updated Apr 14, 2020

Cervical Cord Compression and Hypertension

An observational study in Hypertension, sponsored by Taipei Veterans General Hospital, Taiwan. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-04-14.

Sponsored by Taipei Veterans General Hospital, Taiwan · Observational

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Myelopathy from cervical cord compression may induce hypertension and sympathetic hyperactivity. Anesthesia may suppress sympathetic activity and lead to hypotension that require vasopressor treatment. We aim to elucidate the causative factors for severe hypotension during anesthesia by prospective observational study.

Read the detailed description

It had been reported the cervical spondylotic myelopathy may lead to the development of hypertension. Decompression surgeries ameliorated neurological symptoms as well as the blood pressure. The cause may be the abnormality of autonomic dysfunction developed after myelopathy. However, the evidence was weak. We have noticed a tendency of hypotension during anesthesia in patients undergroing cervical spine surgeries, especially in surgeries of long levels and hypertensive patients. Thus we postulate the autonomic activity is abnormal in patients with cervical myelopathy. Sympathetic hyperactivity developed in order to maintain adequate perfusion to the cervical cord. When patients are under anesthesia, the sympathetic tone is suppressed, thus leading to severe hypotension that require the treatment of inotropic treatment. Heart rate variability (HRV) is a good index of autonomic activity. Thus we plan to Therefore we will measure the HRV (analysis of ECG) and baroreflex activity (analysis of arterial line during the anesthesia) in patients undergoing cervical spine surgeries for decompression of cord compression perioperatively. The primary end-point is the comparison of severity of cord compression between normotensive and hypertensive patients with cervical myelopathy. The secondary end-point is to compare blood pressure and HRV pre- and postoperatively. The third end-point is to elucidate the causative factors for severe hypotension during anesthesia.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • heart rate variability
  • cervical myelopathy
  • blood pressure
  • decompression
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 100 is below the median of 210 across 1,359 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Taipei Veterans General Hospital, Taiwan is the lead sponsor of 325 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We exclude patients with other cormobidity that might lead to hypertension or hypetension. we perfrom age and gender matched pair.

Inclusion criteria

  • cervical spine surgery for cord compression

Exclusion criteria

Exclusion Criteria:

  • spinal cord injury
  • ASA class >3
  • chronic kidney disease
  • congestive heart failure
  • BMI>30
  • atrial fibrillation/ flutter
  • obstructive sleep apnea
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • normotension

    patients without diagnosis or treatment for hypertension

    Procedure: Decompression surgery

  • hypertension

    patients with diagnosis or treatment for hypertension

    Procedure: Decompression surgery

Interventions

  • ProcedureDecompression surgery

    The surgeries aim to relieve the myelopathy from cord compression

    Also known as: cervical spine decompression surgery

06

What researchers measure

Primary outcomes

  1. change of blood pressure

    noninvasive blood pressure

    Time frame: one day before surgery, during surgery, 3 months after surgery, 6 months after surgery

  2. change of hear rate variability

    from analysis of ECG

    Time frame: one day before surgery, during surgery, 3 months after surgery, 6 months after surgery

  3. baroreflex activity

    from analysis of arterial blood pressure waveform

    Time frame: during surgery (anesthesia)

Secondary outcomes

  1. change of Japanese Orthopaedic Association Scores

    17 points neurological assessment for cervical spine pathology (from 0\~17; 0 denotes worst neurological condition, 17 denotes intact )

    Time frame: one day before surgery, 3 months after surgery, 6 months after surgery

  2. change of the Nurick scores

    6 grades neurological assessment for cervical spine pathology (Grade 0: no root or cord symptoms; 1, signs or symptoms of root involvement only; 2, signs of spinal cord involvement (normal gait); 3, mild gait abnormality (does not prevent employment); 4, gait abnormality prevents employment; 5, only able to walk with assistance; 6, chair bound or bedridden)

    Time frame: one day before surgery, 3 months after surgery, 6 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Taipei Veterans General Hospital
    Taipei county, 11217, Taiwan
    • MC Hou · Contact · +886-2-28757381
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04345822
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Responsible party
Sponsor
First posted
Apr 14, 2020
Start date
Feb 1, 2020
Primary completion
Mar 31, 2021 (estimated)
Completion
Aug 31, 2021 (estimated)
Last update
Apr 14, 2020

Study contacts

Ya-Chun Chu, MD, PhD
Contact
yachunchu@gmail.com
+886-2-28757549
Wen-Cheng HUANG, MD, PhD
Contact
wchuang518@gmail.com
+886-2-2875-7716
MC HO, MD, PhD
study chair · Taipei Veterans General Hospital, Taiwan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion